Literature DB >> 25352364

Veratric acid inhibits iNOS expression through the regulation of PI3K activation and histone acetylation in LPS-stimulated RAW264.7 cells.

Woo-Suk Choi1, Yong-Bae Seo1, Pyung-Gyun Shin2, Woe-Yeon Kim3, Sang Yeol Lee3, Young-Ju Choi4, Gun-Do Kim1.   

Abstract

In the present study, we investigated regulatory effects of veratric acid on the production of nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. NO production was significantly decreased by veratric acid in the LPS-stimulated RAW264.7 cells in a dose-dependent manner. The reduction in nitric oxide production was induced by the downregulation of inducible NO synthase (iNOS) expression. Veratric acid suppressed the LPS-induced effects on the regulatory and catalytic subunits of phosphoinositide 3-kinase (PI3K), comprised of p85, p110α, p110β and Akt. The acetylation of p300 and the phosphorylation of activating transcription factor 2 (ATF-2) induced by LPS were downregulated following treatment with veratric acid; similar effects were observed following treatment with LY294002, a specific inhibitor of PI3K/Akt. The LPS-induced expression of histone deacetylase (HDAC)3 decreased to basal levels following treatment with veratric acid, and its expression was also downregulated by LY294002. In the measurement of histone acetylation levels, the LPS-stimulated acetylation of histone H4 was significantly attenuated by veratric acid, and was also reduced following the inhibition of PI3K/Akt with LY294002. From our data, it can be concluded that veratric acid exerts a regulatory effect on LPS-induced iNOS expression. Our results suggest that veratric acid impedes the PI3K/Akt-mediated histone acetyl-transferase (HAT) activation and HDAC expression induced by LPS, thereby abrogating iNOS expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25352364     DOI: 10.3892/ijmm.2014.1982

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

1.  (-)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) Quinic Acid Inhibits the Function of Myeloid-Derived Suppressor Cells to Enhance the Efficacy of Anti-PD1 against Colon Cancer.

Authors:  HongYue Lin; YuZhu Wu; JinPing Chen; ShuRong Huang; YangQiang Wang
Journal:  Pharm Res       Date:  2018-07-30       Impact factor: 4.200

2.  Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

Authors:  Ruth J Davis; Ellen C Moore; Paul E Clavijo; Jay Friedman; Harrison Cash; Zhong Chen; Chris Silvin; Carter Van Waes; Clint Allen
Journal:  Cancer Res       Date:  2017-03-31       Impact factor: 12.701

3.  Veratric Acid Inhibits LPS-Induced IL-6 and IL-8 Production in Human Gingival Fibroblasts.

Authors:  Qi-Bao Wang; Lan-Ying Sun; Zuo-de Gong; Yi Du
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's Disease.

Authors:  Sandeep More; Dong-Kug Choi
Journal:  Nutrients       Date:  2017-05-02       Impact factor: 5.717

5.  Regulatory effects and molecular mechanism of Trigonostemon reidioides on lipopolysaccharide‑induced inflammatory responses in RAW264.7 cells.

Authors:  Ju Young Shin; Jae-Shin Kang; Hye-Woo Byun; Eun-Kyung Ahn
Journal:  Mol Med Rep       Date:  2017-08-21       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.